BioSpace News Archive

Deals

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants.

March 19, 2024
·
4 min read
Business

Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment

Gynesonics®, Inc. is pleased to announce several executive appointments for the positions of Chief Marketing and Strategy Officer, Chief Human Resource Officer, and Vice President of Market Access and Reimbursement.

March 19, 2024
·
5 min read
Biotech Beach

Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development

Blacksmith Medicines, Inc. announced today that it will present a talk and poster highlighting its novel chemistry technology platform for metalloenzyme inhibitors of LpxC being held March 17-22, 2024, in Ventura, CA.

March 19, 2024
·
4 min read
Drug Development

DepYmed Receives Clearance from U.S. Food and Drug Administration to Initiate Phase 1 Clinical Trial for DPM-1003 for the Treatment of Rett Syndrome

DepYmed, Inc. (“DepYmed” or the “Company”) is a clinical-stage pharmaceutical company focused on developing transformative medicines for many poorly treated diseases that may benefit significantly by targeting the protein tyrosine phosphatase (PTP) family of enzymes.

March 19, 2024
·
3 min read
Drug Development

Results from Italfarmaco Pivotal Phase 3 EPIDYS Study of Givinostat in Duchenne Muscular Dystrophy (DMD) Published in The Lancet Neurology

Italfarmaco S.p.A. announced today that the full results from the Company’s pivotal phase 3 EPIDYS clinical trial with givinostat in ambulant boys 6 years of age and older with Duchenne muscular dystrophy (DMD) have been published in The Lancet Neurology.

March 19, 2024
·
7 min read
MaaT Pharma To Present New Preclinical Data at AACR for MaaT034 Aiming To improve Patients’ Responses to Immunotherapies

MaaT Pharma (EURONEXT: MAAT – the “Company”) will present new in vitro data at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place on April 5-10 in San Diego, California.

March 19, 2024
·
3 min read
Biotech Beach

Immunis Publishes Research Showing Secretomes Improve Metabolism and Muscle While Reducing Fat in Aged Models

Immunis Inc. announces the peer-reviewed publication of research by Immunis and the University of Utah’s Professor Micah Drummond.

March 19, 2024
·
3 min read
Business

Unravel Announces Initiation of RVL001 Clinical Trial Material Manufacturing to Support Upcoming US and International Clinical Trials in Rett Syndrome

Unravel Biosciences, Inc., (“Unravel”) today announced a manufacturing and development partnership with Quality Chemical Laboratories, Inc. (QCL) to manufacture RVL001 clinical trial material for use in upcoming Rett syndrome clinical trials in the US and Colombia.

March 19, 2024
·
2 min read
QDx Pathology Services Adopts Proscia’s Software To Improve Speed And Precision

QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory serving medical professionals and facilities throughout the United States

March 19, 2024
·
3 min read
Cell MedX Corp. Closes Private Placement Financing

Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX”, or the “Company”) a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products

March 19, 2024
·
3 min read